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Abstract
Background The Idea, Development, Exploration, Assessment and Long-term study (IDEAL) framework was created to provide
a structured way for assessing and evaluating novel surgical techniques and devices.
Objectives The aim of this paper was to investigate the utilization of the IDEAL framework within neurosurgery, and to identify
factors influencing implementation.
Methods A bibliometric analysis of the 7 key IDEAL papers on Scopus, PubMed, Embase,Web of Science, and Google Scholar
databases (2009–2019) was performed. A second journal-specific search then identified additional papers citing the IDEAL
framework. Publications identified were screened by two independent reviewers to select neurosurgery-specific articles.
Results The citation search identified 1336 articles. The journal search identified another 16 articles. Following deduplication
and review, 51 relevant articles remained; 14 primary papers (27%) and 37 secondary papers (73%). Of the primary papers, 5
(36%) papers applied the IDEAL framework to their research correctly; two were aligned to the pre-IDEAL stage, one to the Idea
and Development stages, and two to the Exploration stage. Of the secondary papers, 21 (57%) explicitly discussed the IDEAL
framework. Eighteen (86%) of these were supportive of implementing the framework, while one was not, and two were neutral.
Conclusion The adoption of the IDEAL framework in neurosurgery has been slow, particularly for early-stage neurosurgical
techniques and inventions. However, the largely positive reviews in secondary literature suggest potential for increased use that
may be achieved with education and publicity.
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Introduction
With technological advances leading to rapid development of
new devices and operative techniques, it remains imperative
that we critically assess novel ideas to ensure they confer true
patient benefit. Innovative solutions to unique problems are
reliant on creativity and lateral thinking, which can appear at
odds with the rules and regulations required to systematically
appraise developments. However, it is in the interest of patient
safety and the society to ensure that widespread implementa-
tion occurs after rigorous assessment and research [18].
The IDEAL framework is a straightforward and structured
approach that can guide evaluation and research across all
surgical fields, while also allowing enough flexibility to pre-
vent stifling of innovation. First published in 2009 [41], it was
developed to provide guidance on the evaluation of surgical
techniques and devices from inception to long-term
evaluation [7]. It consists of 5 stages: Idea, Development,
Exploration, Assessment, and Long-term studies. Each stage
includes various recommendations to ensure that high-quality
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evidence is obtained when studying new ideas, as demonstrat-
ed in Table 1.
This framework differs from the traditional model of phar-
macological trials to accommodate the distinct way surgical
developments occur, particularly since individual operator
skill and technique modifications at the early stages can dif-
ferentially impact outcomes.[46]. A subsequent paper intro-
duced Stage 0, a preclinical stage, for testing involving ca-
davers, animals, or simulations, while another clarified the
use of the IDEAL framework in surgical device development
[25, 56]. The IDEAL structure adds value to surgical innova-
tion by ensuring safety and regulation; however, uptake has
varied across various countries and surgical specialties. While
utilization has increased overall, this has predominantly hap-
pened in other surgical fields [28]. A recent review of the
IDEAL framework applied within minimally invasive neuro-
surgical research assessed historical studies involved in the
development of the endoscopic endonasal approach for skull
base meningiomas and theWoven EndoBridge (WEB) device
for endovascular treatment of intracranial aneurysms [48].
The authors assessed the quality of the research that contrib-
uted to these developments by measuring the adherence of
various studies to IDEAL guidelines. Their search revealed a
total of four clinical papers that could be aligned with any
stage of the IDEAL framework.
The aim of this bibliometric review is to investigate the
adoption of the IDEAL framework in neurosurgical literature
as a whole and reflect on factors influencing implementation
since its inception 10 years ago.
Methodology
We performed individual citation searches for the seven main
IDEAL papers [13, 18, 19, 25, 41, 42, 56] on Scopus,
PubMed, Embase, Web of Science, and Google Scholar data-
bases (September 2009 to August 2019). Articles were iden-
tified and analyzed by two independent reviewers, CO and
BS. These searches were completed on each database individ-
ually. Papers identified were stored and deduplicated in
Mendeley reference manager. The titles and abstracts of all
papers were then screened for relevance to the study by the
two independent reviewers, followed by full text review; the
final selection was reviewed by a third independent reviewer
to ensure suitability for inclusion (AA). Any disagreements
were resolved following discussion with the senior author
(AK). All papers with a focus on neurosurgical techniques
or devices published between September 2009 and August
2019 were included. Non-English papers and non-journal text
(such as book chapters) were excluded. This methodology
was first used by Tradewell et al., investigating the use of
the IDEAL framework in urological research [57]. Ta
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For completeness, a second search using the terms “IDEAL
Collaboration” and “IDEAL framework” was performed in
the following major neurosurgical journals: Acta
Neurochirurgica, British Journal of Neurosurgery, Child’s
Nervous System, Clinical Neurology and Neurosurgery,
Journal of Clinical Neuroscience, Journal of Korean
Neurosurgical Society, Journal of Neurology, Neurosurgery
and Psychiatry, Journal of Neurosurgery, Journal of
Neurosurgery: Pediatrics, Journal of Neurosurgery: Spine,
Journal of Neurosurgical Sciences, Neurosurgery,
Neurosurgery Clinics of North America and Clinical
Neurosurgery, Neurosurgical Focus, Neurosurgical Review,
Pediatric Neurosurgery, Stereotactic and Functional
Neurosurgery , Turkish Neurosurgery , and World
Neurosurgery.
Primary papers were defined as original research publica-
tions assessing new surgical techniques or devices, and were
linked to the most relevant stage of the IDEAL protocol (many
self-identified) and assessed for adherence to criteria for that
stage. Secondary papers included systematic reviews, opinion
pieces, and letters to the editor; these were assessed with re-
gard to their support for and evaluation of the IDEAL papers
and framework.
Results
The citation search identified 1336 articles, while the second-
ary search identified another 16 (see Fig. 1). Following
deduplication and abstract review, 51 relevant articles were
identified. Thereafter remained fourteen primary papers [8,
17, 20, 26, 33, 34, 37, 39, 46, 51, 55, 58–60], and 37 second-
ary papers [1–5, 9–12, 14–16, 23, 27, 29–32, 35, 36, 38, 40,
43–45, 47–50, 52–54, 57, 62, 64–66].
Articles were published from 2010 to July 2019 (date of
citation search), with a peak in 2018. The top 3 journals for
publications that cited the IDEAL articles were Acta
Neurochirurgica (n = 8), Journal of Neurosurgery (n = 5),
and World Neurosurgery (n = 5).
Fig. 1 Diagram outlining search strategy
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Primary publication analysis
All of the fourteen primary publications identified were from
European groups. Papers were published between 2013 and
2019 and spanned a number of sub-specialties including skull
base, neuro-oncology, and spinal neurosurgery. Ten papers
(71%) explicitly mention the IDEAL framework within their
text [8, 20, 26, 33, 34, 37, 39, 55, 58, 60]. Six (43%) papers
aimed to align their research with a specific stage of the
IDEAL framework [8, 20, 33, 34, 39, 60]. Of these six, five
(83%) papers appropriately applied the IDEAL framework to
their research; one publication claiming to align to stage 1/2a
was an animal study [8]. Animal studies are technically stage
0, the preclinical stage of the IDEAL framework [33].
Of the five papers appropriately staged, their adherence to
IDEAL recommendation including study size, ethical over-
sight, and outcome measures are presented in Table 2.
The paper by Belotti et al. aligned with Stage 0, the
preclinical stage of the IDEAL framework [8]. This study
involved the use of 10 specimens for testing in one clinical
center, another two for filming in a second center. The pur-
pose of the study was to improve safety and effectiveness of
the transsphenoidal approach by categorizing different ap-
proaches, aligning with Stage 0. Marcus et al. also aligned
their study to Stage 0, within the IDEAL-D framework spe-
cific to devices; comparing the use of computer-assisted
planning with manual planning in stereotactic brain biopsy
[39]. The study by Versteeg et al. that investigated spinal
stabilization following radiotherapy had two arms. Each
arm was applied appropriately to the Idea (1) and
Development (2a) stages with samples sizes of 3 and 10,
respectively [60]. Adverse events were evaluated and clas-
sified according to the common toxicity criteria adverse
events during a median clinical follow-up time of
13 months. The study by Majovsky et al. was stage 2a
and assessed the use of burr holes in evacuation of chronic
subdural hematomas [34]. The paper by Flores et al. was
also aligned to stage 2a, investigating the use of syringes as
dilators and retractors in spinal surgery in 30 patients [20].
None of the studies included from the citation search iden-
tified as stage 2b, 3, or 4 (exploration, assessment, long-
term monitoring).
Secondary publication analysis
Thirty-seven secondary papers were identified. Of them, 13
(35%) were narrative reviews [9, 11, 15, 27, 29–31, 43–45,
52, 53, 64]. Eleven (30%) were systematic reviews [1, 5, 10,
14, 16, 38, 40, 46, 48, 49, 66].
The remaining papers identified are consist of 10 letters to
the editor (27%) [2–4, 12, 23, 32, 36, 47, 50, 54], 2
questionnaire-based analyses (one exploring views on the
use of evidence-based medicine principles in neurosurgery,
the other seeking to understand the neurosurgical definition
of “innovation”) [62, 65], and 1 article outlining the work of
the British Neurosurgical Trainee Collaborative [57].
Of the secondary publications, 21 (57%) explicitly men-
tioned the IDEAL framework [1, 3, 5, 10–12, 14, 15, 29, 32,
38, 43, 47–50, 52, 53, 57, 60, 65], while the rest cited the
IDEAL publications, but did not discuss them. Of the 21 pa-
pers that discussed the IDEAL framework, 18 (86%) were
supportive of the use of the IDEAL framework [3, 5, 10–12,
Table 2 Publication adherence to IDEAL framework (N/A refers to criteria not necessary to fulfill a specific stage of the IDEAL framework)
Belotti et al.[8] Versteeg et al.[60] Majovsky et al.[34] Flores et al.[20] Marcus et al.[39]
IDEAL stage 0 1/2a 2a 2a 0 (Ideal-D)
Study Size (Mean) 10 specimen 3 (Stage 1),
10 (Stage 2a)
18 30 15
Follow up time (months, mean) N/A 13 9.3 6.5 N/A
Number of surgeons reported
(number of surgeons)
No (N/A) No (N/A) No (N/A) No (N/A) Yes (4)
Number of clinical sites reported
(mean number of clinical sites)
Yes (2) Yes (1) No (N/A) No (N/A) Yes (1)
Prospective study N/A Yes Yes No N/A
Prior published/registered protocol N/A N/A No No N/A
Safety/feasibility of procedure considered Yes N/A N/A Yes Yes
Ethical oversight N/A Yes No No N/A
Document adverse outcomes N/A Yes Yes Yes N/A
Sequential reporting of outcomes N/A Yes Yes Yes N/A
Patient reported outcomes N/A No Yes Yes N/A
Participants registered in a database N/A No No No N/A
Surgeons view of procedures considered N/A No N/A No N/A
Documented funding No Yes Yes No Yes
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14, 15, 29, 32, 38, 43, 47, 49, 50, 52, 53, 57, 60], while 1 paper
was not [1], and 2 were neutral [48, 65]. Six of these publica-
tions evaluated the applicability of the IDEAL framework in
neurosurgical innovation [38, 47, 48, 50, 64, 65].
Discussion
The aim of this study was to explore the adoption of the
IDEAL framework within neurosurgery by reviewing cita-
tions of the key IDEAL papers. The citation search allowed
us to assess awareness of the framework, and examine the way
in which it is utilized. This methodology was informed by the
work of Tradewell et al. who also used a citation search to
review the use of the IDEAL framework in urological litera-
ture [21]. Given the large number of citations of these papers
in urological literature, it is clear that the framework has im-
pacted thinking in surgical development; however, this does
not seem to be reflected particularly in neurosurgery, evident
by the small number of papers that specifically cited the
framework, or were aligned to a specific stage of the frame-
work. Encouragingly, the number of neurosurgical papers
referencing the framework has shown a year on year increase;
however, numbers remain relatively small.
There are several factors that could contribute to the limited
uptake of the IDEAL framework in neurosurgery. A potential
cause is a lack of awareness. The IDEAL framework was
developed in the UK, and initially published in 2009 [41].
Though there are a number of articles that outline the
IDEAL framework and its recommendations, it is possible
that those involved in current research and surgical develop-
ment are either not aware, or not particularly well versed in the
framework. This is supported by our finding that all primary
papers were of European origin. It is also important to consid-
er that many researchers may not have considered the need for
a framework specifically designed for surgical innovation, and
therefore did not seek one out. Given the low numbers of
primary papers that cited and applied the IDEAL framework
to their research, and given that some of these papers did so
incorrectly or incompletely, it is clear that education on the
IDEAL framework is still actively required to guide re-
searchers and authors, a problem also identified by
Khachane et al. [28]. The IDEAL council has identified this
potential issue, and encourages surgeons from all specialties
and any country to join the collaboration, particularly through
the use of a diverse group of council advisors and specialty
leads from a number of different countries and specialties,
who help to develop and promote the IDEAL framework.
The IDEAL council view the framework as ever-evolving in
response to pragmatic need and a requirement to learn from
IDEAL’s end-users. The update paper was also published in
the Annals of Surgery, a US Journal, to further increase the
reach of the framework [25].
It is also important to consider how applicable the frame-
work is to neurosurgical research. Surgical innovation and
technical development differ between specialties and even
sub-specialties, as illustrated in Muskens et al.’s examination
of innovation within endoscopic endonasal surgery for skull
base meningiomas versus the Woven EndoBridge device for
endovascular treatment of intracranial aneurysms. When they
explored mapping those developments to the IDEAL frame-
work, only four of the 21 papers included could be matched to
any stage of the IDEAL framework: two papers to Stage 2A
and two to 2B [48]. Looking specifically at the lack of papers
that align with stage 2B, as replicated by our own results, a
potential reason for the low numbers of this type of study is
that neurosurgical research still largely follows the traditional
model of a phase 2 randomized trial that may or may not be
followed by a phase 3 randomized trial. A recent example is
the MISTIE II and MISTIE III trials (phase 2 and phase 3
trials), which evaluated a new technique for evacuation of
intracerebral hemorrhage (ICH) [22, 63]. Given these studies
fulfill much of the criteria for IDEAL stages 2b and 3, it is
clear that potential to align these studies is the IDEAL frame-
work is present; however, tradition or simply lack of aware-
ness of the IDEAL framework may have prevented this.
Another potential reason is that, as is often the case with
surgical research, there is an overreliance on retrospective
“case series.” This is likely because case series are easy to
perform, require less resources, can be conducted at a single
center, and, for many surgeons, are means to showcase their
surgical skills and outcomes [61]. Furthermore these studies
afford a flexibility that may not be afforded by adhering strict-
ly to the IDEAL framework. Some surgeons would argue that
limiting this flexibility stifles innovation. However, the true
aim of the framework is to facilitate the conduct of well-
designed and well-executed studies in order to facilitate the
adoption of innovative techniques, if found to be effective. A
recent example is the use of middle meningeal artery (MMA)
embolization for chronic subdural hematomas (CSDH), where
the majority of conducted studies are case series [6]. Although
this procedure is clearly innovative, many of the studies re-
ported use of MMA embolization for atypical indications
(e.g., asymptomatic patients, as “prophylaxis” after surgery)
outside the context of ethically approved research.
The lack of IDEAL stage 3 studies, which are typically a
definitive, multi-center randomized trial, can be explained by
the fact that these studies are usually identified as phase 3 trials
or simply randomized trials, despite technically meeting the
criteria of a stage 3 IDEAL study. A recent review identified
401 published randomized trials on brain and spine conditions
treated by neurosurgeons from 2003 to 2016 [24]. Given these
numbers, it appears that randomized trials are possible within
neurosurgical innovation, and therefore the potential for stage
2b and stage 3 IDEAL studies is much greater than what is
currently present. In order to investigate this further,
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qualitative feedback should be sought from neurosurgeons on
the applicability of the IDEAL framework to their research, in
order to identify factors that have limited or prevented use.
This information may in turn be used to guide future updates
of the framework, and educational materials used within the
neurosurgical community.
As most developments occur in incremental improvements
upon techniques or devices, the appropriateness of large ran-
domized controlled trials for each small, additive change is
questionable. However, this would not apply to innovations,
such as MMA embolization or the MISTIE procedure, which
are entirely different to the usual method of treating CSDH
and ICH, respectively [21, 22, 61]. There are also ethical con-
siderations; if a new technique or surgical device displays a
substantial, unequivocal benefit over past standard (e.g. the
introduction of microscope in micro-neurosurgery), the lack
of clinical equipoise precludes conducting a trial that may
expose patients to suboptimal treatment.
There are also ongoing concerns that neurosurgical ran-
domized trials are often not feasible or impractical [64].
Some authors suggest that routinely collected or observational
data can lead to robust conclusions regarding the comparative
effectiveness of treatment; however, this is a relatively new
field with ongoing methodological challenges. As an exam-
ple, a recent study found that observational studies based on
routinely collected health data could give different answers
from subsequent randomized trials on the same clinical ques-
tions and may substantially overestimate treatment effects [6].
Reasons for this are likely multiple, and while this difference
could reflect a difference in validity achieved by the different
study methodologies, it is important to consider the impact the
highly selective populations used for randomized trials could
have on research outcomes, in comparison with the broader
populations that usually contribute to observational studies.
Another option, which is gaining traction in recent years, is
the use of pragmatic large randomized trials that have broad
inclusion criteria in order to reflect real-world practice. The
IDEAL collaboration is working on developing guidance on
the use of real-world evidence for the purposes of comparative
effectiveness research.
The most recent IDEAL publication, a follow up to the first
paper, has elaborated more on the recommendations and how
to apply them for each stage [25]. It is hoped that this new
update of the IDEAL framework will improve the understand-
ing of where the framework can fit within neurosurgery and
therefore improve uptake. Further projects include stage-
specific reporting guidelines developed using Delphi method-
ology. Given that the majority of secondary papers that cited
the IDEAL framework were supportive of its use, it would
seem that education, promotion, and room for specialty-
specific nuance within recommendations could largely im-
prove uptake, and in turn help guide neurosurgical develop-
ment to produce a high-quality evidence base for our practice.
Limitations of this paper
This paper reviewed articles that cited the IDEAL framework
key papers. It is possible that there are studies that have ad-
hered to and referenced the framework, but have not cited
these papers and are therefore excluded from this review.
The secondary journal specific search aimed to negate this
limitation; however, this solely identified articles within the
selection of journals searched (listed above). Papers published
in other journals will not have been identified in this search. It
is also possible that there is a research that has unintentionally
adhered to the IDEAL framework but has not been included,
again as they have not cited the IDEAL papers. Evaluation of
the papers and their adherence to the IDEAL framework rec-
ommendation (primary papers) or support of the IDEAL
framework (secondary papers) was subjective, as based on
the opinion and understanding of the authors of this paper.
Conclusion
Ultimately, in order to fully evaluate the potential for the
IDEAL framework in neurosurgical research, it is necessary
that more primary research studies attempt to follow the rec-
ommendations. Feedback highlighting neurosurgery-specific
limitations can be generated and incorporated into future iter-
ations of the framework. This will ensure that it is able to
support and work with nuances and specialty-specific con-
cerns that are causing limited use of the IDEAL framework
thus far.
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Comments
The IDEAL framework represents a set of steps whose goal is that of
generating sound innovations in Surgery while assuring adequate ethics
and patient awareness compliance. These recommendations were first
published in 2009 following a series of meetings at Balliol College,
Oxford, during 2007 to 2009 to discuss the specific challenges of
evaluating surgical innovation (1).
A review of the evolving IDEAL recommendations is provided by
Hirst et al. in 2019 (2). The paper by CUOta et al analyzes the penetration
of the Ideal framework in Neurosurgical publications. It identifies
primary papers where an attempt is made to follow Ideal
recommendations in the construction of the study and secondary
papers in which the Ideal recommendations are discussed in the text or
simply mentioned in the Reference section.
The results show a low penetration of the IDEAL instrument with 14
primary papers and 37 secondary papers representing 4% of a total of
1336 articles evaluated.
The authors suggest a number of reasons for this low uptake including
overreliance on time-honored retrospective case series and lack of aware-
ness of the IDEAL concept, including a few studies which in practicality
conform to IDEAL recommendations but fail to mention them. While
these explanations may play a more or less relevant role, a perhaps bigger
role may be linked to the over-enthusiasm of the surgical innovator for
her/his innovation that might not be validated if a more stringent evalu-
ation, such as the IDEAL one, was to be sought.
What to do about the current situation? Demand more accountability
on the proposed innovations, highlighting what the proposed innovation
is going to ameliorate and what is the process chosen to validate it.
In this context, a more widespread use of the Ideal recommendations
could be very useful.
We fully agree with the authors that a more robust education of the
Neurosurgical communi ty on the concept of the IDEAL
recommendations is warranted and, we add, should be actively pursued
by Neurosurgical Societies worldwide.
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